Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Gareth John Parry, PH.D.

TitleAssistant Clinical Professor of Pediatrics
InstitutionChildren's Hospital Boston
DepartmentPediatrics
AddressNatl. Initiative for Healthcare Improvement
7th Floor
20 University Rd
Cambridge MA 02138

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Parry G, Cline A, Goldmann D. Deciphering harm measurement. JAMA. 2012 May 23; 307(20):2155-6.
    View in: PubMed
  2. Feudtner C, Berry JG, Parry G, Hain P, Morse RB, Slonim AD, Shah SS, Hall M. Statistical uncertainty of mortality rates and rankings for children's hospitals. Pediatrics. 2011 Oct; 128(4):e966-72.
    View in: PubMed
  3. Porter SC, Johnston P, Parry G, Damian F, Hoppa EC, Stack AM. Improving parent-provider communication in the pediatric emergency department: results from the clear and concise communication campaign. Pediatr Emerg Care. 2011 Feb; 27(2):75-80.
    View in: PubMed
  4. Gorson KC, van Schaik IN, Merkies IS, Lewis RA, Barohn RJ, Koski CL, Cornblath DR, Hughes RA, Hahn AF, Baumgarten M, Goldstein J, Katz J, Graves M, Parry G, van Doorn PA. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst. 2010 Dec; 15(4):326-33.
    View in: PubMed
  5. Landrigan CP, Parry GJ, Bones CB, Hackbarth AD, Goldmann DA, Sharek PJ. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010 Nov 25; 363(22):2124-34.
    View in: PubMed
  6. Sharek PJ, Parry G, Goldmann D, Bones K, Hackbarth A, Resar R, Griffin FA, Rhoda D, Murphy C, Landrigan CP. Performance characteristics of a methodology to quantify adverse events over time in hospitalized patients. Health Serv Res. 2011 Apr; 46(2):654-78.
    View in: PubMed
  7. Parry G, Horowitz L, Goldmann D. Patient safety attitudes of paediatric trainee physicians. Qual Saf Health Care. 2009 Dec; 18(6):462-6.
    View in: PubMed
  8. Muley SA, Parry GJ. Inflammatory demyelinating neuropathies. Curr Treat Options Neurol. 2009 May; 11(3):221-7.
    View in: PubMed
  9. Hillier DF, Parry GJ, Shannon MW, Stack AM. The effect of hospital bed occupancy on throughput in the pediatric emergency department. Ann Emerg Med. 2009 Jun; 53(6):767-76.e3.
    View in: PubMed
  10. Morrell CJ, Slade P, Warner R, Paley G, Dixon S, Walters SJ, Brugha T, Barkham M, Parry GJ, Nicholl J. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ. 2009; 338:a3045.
    View in: PubMed
  11. Landsverk ML, Ruzzo EK, Mefford HC, Buysse K, Buchan JG, Eichler EE, Petty EM, Peterson EA, Knutzen DM, Barnett K, Farlow MR, Caress J, Parry GJ, Quan D, Gardner KL, Hong M, Simmons Z, Bird TD, Chance PF, Hannibal MC. Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum Mol Genet. 2009 Apr 1; 18(7):1200-8.
    View in: PubMed
  12. Parslow RC, Tasker RC, Draper ES, Parry GJ, Jones S, Chater T, Thiru K, McKinney PA. Epidemiology of critically ill children in England and Wales: incidence, mortality, deprivation and ethnicity. Arch Dis Child. 2009 Mar; 94(3):210-5.
    View in: PubMed
  13. Koski CL, Baumgarten M, Magder LS, Barohn RJ, Goldstein J, Graves M, Gorson K, Hahn AF, Hughes RA, Katz J, Lewis RA, Parry GJ, van Doorn P, Cornblath DR. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2009 Feb 15; 277(1-2):1-8.
    View in: PubMed
  14. Muley SA, Kelkar P, Parry GJ. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol. 2008 Nov; 65(11):1460-4.
    View in: PubMed
  15. Schulman J, Spiegelhalter DJ, Parry G. How to interpret your dot: decoding the message of clinical performance indicators. J Perinatol. 2008 Sep; 28(9):588-96.
    View in: PubMed
  16. Ashok Muley S, Brown K, Parry GJ. Paraneoplastic vasculitic neuropathy related to carcinoid tumor. J Neurol. 2008 Jul; 255(7):1085-7.
    View in: PubMed
  17. Kaltenthaler E, Sutcliffe P, Parry G, Beverley C, Rees A, Ferriter M. The acceptability to patients of computerized cognitive behaviour therapy for depression: a systematic review. Psychol Med. 2008 Nov; 38(11):1521-30.
    View in: PubMed
  18. Georgopoulos AP, Karageorgiou E, Leuthold AC, Lewis SM, Lynch JK, Alonso AA, Aslam Z, Carpenter AF, Georgopoulos A, Hemmy LS, Koutlas IG, Langheim FJ, McCarten JR, McPherson SE, Pardo JV, Pardo PJ, Parry GJ, Rottunda SJ, Segal BM, Sponheim SR, Stanwyck JJ, Stephane M, Westermeyer JJ. Synchronous neural interactions assessed by magnetoencephalography: a functional biomarker for brain disorders. J Neural Eng. 2007 Dec; 4(4):349-55.
    View in: PubMed
  19. McDonnell A, Esmonde L, Morgan R, Brown R, Bray K, Parry G, Adam S, Sinclair R, Harvey S, Mays N, Rowan K. The provision of critical care outreach services in England: findings from a national survey. J Crit Care. 2007 Sep; 22(3):212-8.
    View in: PubMed
  20. Parry G. Future trends in illness severity scores. Intensive Care Med. 2007 Sep; 33(9):1501-2.
    View in: PubMed
  21. Harrison DA, Parry GJ, Carpenter JR, Short A, Rowan K. A new risk prediction model for critical care: the Intensive Care National Audit & Research Centre (ICNARC) model. Crit Care Med. 2007 Apr; 35(4):1091-8.
    View in: PubMed
  22. Gao H, McDonnell A, Harrison DA, Moore T, Adam S, Daly K, Esmonde L, Goldhill DR, Parry GJ, Rashidian A, Subbe CP, Harvey S. Systematic review and evaluation of physiological track and trigger warning systems for identifying at-risk patients on the ward. Intensive Care Med. 2007 Apr; 33(4):667-79.
    View in: PubMed
  23. Harrison DA, Parry GJ, Rowan K. Risk prediction models: recalibration. Crit Care Med. 2007 Jan; 35(1):326-7.
    View in: PubMed
  24. Gao H, Harrison DA, Parry GJ, Daly K, Subbe CP, Rowan K. The impact of the introduction of critical care outreach services in England: a multicentre interrupted time-series analysis. Crit Care. 2007; 11(5):R113.
    View in: PubMed
  25. Jones S, Rantell K, Stevens K, Colwell B, Ratcliffe JR, Holland P, Rowan K, Parry GJ. Outcome at 6 months after admission for pediatric intensive care: a report of a national study of pediatric intensive care units in the United kingdom. Pediatrics. 2006 Nov; 118(5):2101-8.
    View in: PubMed
  26. Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K, Paisley S. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. Health Technol Assess. 2006 Sep; 10(35):iii, ix-xii, 1-117.
    View in: PubMed
  27. Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess. 2006 Sep; 10(33):iii, xi-xiv, 1-168.
    View in: PubMed
  28. Thomson RM, Parry GJ. Neuropathies associated with excessive exposure to lead. Muscle Nerve. 2006 Jun; 33(6):732-41.
    View in: PubMed
  29. Harrison DA, Brady AR, Parry GJ, Carpenter JR, Rowan K. Recalibration of risk prediction models in a large multicenter cohort of admissions to adult, general critical care units in the United Kingdom. Crit Care Med. 2006 May; 34(5):1378-88.
    View in: PubMed
  30. Brady AR, Harrison D, Black S, Jones S, Rowan K, Pearson G, Ratcliffe J, Parry GJ. Assessment and optimization of mortality prediction tools for admissions to pediatric intensive care in the United kingdom. Pediatrics. 2006 Apr; 117(4):e733-42.
    View in: PubMed
  31. Profit J, Zupancic JA, McCormick MC, Richardson DK, Escobar GJ, Tucker J, Tarnow-Mordi W, Parry G. Moderately premature infants at Kaiser Permanente Medical Care Program in California are discharged home earlier than their peers in Massachusetts and the United Kingdom. Arch Dis Child Fetal Neonatal Ed. 2006 Jul; 91(4):F245-50.
    View in: PubMed
  32. Muley SA, Parry GJ, Ercan-Fang NG. Isolated bibrachial plexopathy in a patient with type 2 diabetes. Diabetes Care. 2005 Oct; 28(10):2591-2.
    View in: PubMed
  33. Parry GJ, Tucker JS, Tarnow-Mordi WO. Relationship between probable nosocomial bacteraemia and organisational and structural factors in UK neonatal intensive care units. Qual Saf Health Care. 2005 Aug; 14(4):264-9.
    View in: PubMed
  34. McKinney PA, Jones S, Parslow R, Davey N, Darowski M, Chaudhry B, Stack C, Parry G, Draper ES. A feasibility study of signed consent for the collection of patient identifiable information for a national paediatric clinical audit database. BMJ. 2005 Apr 16; 330(7496):877-9.
    View in: PubMed
  35. Fisher AJ, Rutherford RM, Bozzino J, Parry G, Dark JH, Corris PA. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant. 2005 Mar; 5(3):537-43.
    View in: PubMed
  36. Parry G, Draper ES, McKinney P. Paediatric cardiac surgical mortality after Bristol: details of risk adjustment tools were not given. BMJ. 2005 Jan 1; 330(7481):43; author reply 44.
    View in: PubMed
  37. Tucker J, Parry G, Fowlie PW, McGuire W. Organisation and delivery of perinatal services. BMJ. 2004 Sep 25; 329(7468):730-2.
    View in: PubMed
  38. Weatherley-Jones E, Nicholl JP, Thomas KJ, Parry GJ, McKendrick MW, Green ST, Stanley PJ, Lynch SP. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res. 2004 Feb; 56(2):189-97.
    View in: PubMed
  39. Walk D, Li LY, Parry GJ, Day JW. Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg. Neurology. 2004 Jan 13; 62(1):155-6.
    View in: PubMed
  40. Walk D, Zaretskaya M, Parry GJ. Symptom duration and clinical features in painful sensory neuropathy with and without nerve conduction abnormalities. J Neurol Sci. 2003 Oct 15; 214(1-2):3-6.
    View in: PubMed
  41. Parry G, Hacking C, Bamford J, Day J. Minimal response levels for visual reinforcement audiometry in infants. Int J Audiol. 2003 Oct; 42(7):413-7.
    View in: PubMed
  42. Tucker J, Parry G, Penney G, Page M, Hundley V. Is midwife workload associated with quality of process of care (continuous electronic fetal monitoring [CEFM]) and neonatal outcome indicators? A prospective study in consultant-led labour wards in Scotland. Paediatr Perinat Epidemiol. 2003 Oct; 17(4):369-77.
    View in: PubMed
  43. Kilfoyle D, Kelkar P, Parry GJ. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. J Clin Neuromuscul Dis. 2003 Jun; 4(4):168-70.
    View in: PubMed
  44. Kelkar P, Parry GJ. Mononeuritis multiplex in diabetes mellitus: evidence for underlying immune pathogenesis. J Neurol Neurosurg Psychiatry. 2003 Jun; 74(6):803-6.
    View in: PubMed
  45. Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, Cohen JA, Page JC, Bromberg MB, Schwartz SL. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil. 2003 May; 84(5):736-46.
    View in: PubMed
  46. Bryan WW, Hoagland RJ, Murphy J, Armon C, Barohn RJ, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA, Stromatt SC. Can we eliminate placebo in ALS clinical trials? Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr; 4(1):11-5.
    View in: PubMed
  47. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003 Mar 25; 60(6):898-904.
    View in: PubMed
  48. Parry G, Tucker J, Tarnow-Mordi W. Volume of procedures and outcome of treatment. NHS needs to understand relation more effectively. BMJ. 2003 Feb 1; 326(7383):280.
    View in: PubMed
  49. Wolfe GI, Barohn RJ, Foster BM, Jackson CE, Kissel JT, Day JW, Thornton CA, Nations SP, Bryan WW, Amato AA, Freimer ML, Parry GJ. Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve. 2002 Oct; 26(4):549-52.
    View in: PubMed
  50. Kelkar P, McDermott WR, Parry GJ. Sensory-predominant, painful, idiopathic neuropathy: inflammatory changes in sural nerves. Muscle Nerve. 2002 Sep; 26(3):413-6.
    View in: PubMed
  51. Day JW, Sakamoto C, Parry GJ, Lehmann-Horn F, Iaizzo PA. Force assessment in periodic paralysis after electrical muscle stimulation. Mayo Clin Proc. 2002 Mar; 77(3):232-40.
    View in: PubMed
  52. Kumar N, Muley S, Pakiam A, Parry GJ. Phenotypic Variability Leads to Under-recognition of HNPP. J Clin Neuromuscul Dis. 2002 Mar; 3(3):106-12.
    View in: PubMed
  53. Meechan JG, Parry G, Rattray DT, Thomason JM. Effects of dental local anaesthetics in cardiac transplant recipients. Br Dent J. 2002 Feb 9; 192(3):161-3.
    View in: PubMed
  54. Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J. A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technol Assess. 2002; 6(22):1-89.
    View in: PubMed
  55. Gominak S, Parry GJ. Diabetic neuropathy. Adv Neurol. 2002; 88:99-109.
    View in: PubMed
  56. Parry G, Jones S, Simic-Lawson M. Calibration of the paediatric index of mortality in UK paediatric intensive care units. Arch Dis Child. 2002 Jan; 86(1):65; author reply 65-6.
    View in: PubMed
  57. Curtis HJ, Parry G, Dark JH. What have we learnt from the Alder Hey affair? February 2001 seems to have been average month for organ donations in Newcastle. BMJ. 2001 Jun 23; 322(7301):1541.
    View in: PubMed
  58. Miller RG, Moore DH, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, Bryan W, Ravits J, Yuen E, Neville H, Ringel S, Bromberg M, Petajan J, Amato AA, Jackson C, Johnson W, Mandler R, Bosch P, Smith B, Graves M, Ross M, Sorenson EJ, Kelkar P, Parry G, Olney R. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology. 2001 Apr 10; 56(7):843-8.
    View in: PubMed
  59. Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001 Feb 27; 56(4):445-9.
    View in: PubMed
  60. Day J, Bamford J, Parry G, Shepherd M, Quigley A. Evidence on the efficacy of insert earphone and sound field VRA with young infants. Br J Audiol. 2000 Dec; 34(6):329-34.
    View in: PubMed
  61. Kelkar P, Masood M, Parry GJ. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology. 2000 Jul 12; 55(1):83-8.
    View in: PubMed
  62. Hagander LG, Midani HA, Kuskowski MA, Parry GJ. Quantitative sensory testing: effect of site and pressure on vibration thresholds. Clin Neurophysiol. 2000 Jun; 111(6):1066-9.
    View in: PubMed
  63. Hagander LG, Midani HA, Kuskowski MA, Parry GJ. Quantitative sensory testing: effect of site and skin temperature on thermal thresholds. Clin Neurophysiol. 2000 Jan; 111(1):17-22.
    View in: PubMed
  64. Kumar N, Cole J, Parry GJ. Variability of presentation in hereditary neuropathy with liability to pressure palsy results in underrecognition. Ann N Y Acad Sci. 1999 Sep 14; 883:344-50.
    View in: PubMed
  65. Li LY, Kelkar P, Exconde RE, Day J, Parry GJ. Adult-onset "infant" botulism: an unusual cause of weakness in the intensive care unit. Neurology. 1999 Sep 11; 53(4):891.
    View in: PubMed
  66. Parry G. Psychotherapy for severe personality disorder. Author should have got the facts right. BMJ. 1999 Sep 11; 319(7211):710; author reply 710-1.
    View in: PubMed
  67. Parry GJ. Management of diabetic neuropathy. Am J Med. 1999 Aug 30; 107(2B):27S-33S.
    View in: PubMed
  68. Parry GJ. Are multifocal motor neuropathy and Lewis-Sumner syndrome distinct nosologic entities? Muscle Nerve. 1999 May; 22(5):557-9.
    View in: PubMed
  69. Yarnitsky D, Sprecher E, Zaslansky R, Baron R, Bowsher D, Boivie J, Casey K, Claus D, Hanson P, Lindblom U, Marchettini P, Parry GJ, Verdugo R. Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology. 1999 Mar 10; 52(4):894; author reply 894-5.
    View in: PubMed
  70. Parry G, Holt ND, Dark JH, McComb JM. Declining need for pacemaker implantation after cardiac transplantation. Pacing Clin Electrophysiol. 1998 Nov; 21(11 Pt 2):2350-2.
    View in: PubMed
  71. Soiffer R, Lynch T, Mihm M, Jung K, Rhuda C, Schmollinger JC, Hodi FS, Liebster L, Lam P, Mentzer S, Singer S, Tanabe KK, Cosimi AB, Duda R, Sober A, Bhan A, Daley J, Neuberg D, Parry G, Rokovich J, Richards L, Drayer J, Berns A, Clift S, Cohen LK, Mulligan RC, Dranoff G. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):13141-6.
    View in: PubMed
  72. Muley SA, Midani HA, Rank JM, Carithers R, Parry GJ. Neuropathy in erythropoietic protoporphyrias. Neurology. 1998 Jul; 51(1):262-5.
    View in: PubMed
  73. Parry GJ, Gould CR, McCabe CJ, Tarnow-Mordi WO. Annual league tables of mortality in neonatal intensive care units: longitudinal study. International Neonatal Network and the Scottish Neonatal Consultants and Nurses Collaborative Study Group. BMJ. 1998 Jun 27; 316(7149):1931-5.
    View in: PubMed
  74. Midani H, Truwit CL, Parry GJ. MRI in juvenile ALS: a patient report. Neurology. 1998 Jun; 50(6):1879-81.
    View in: PubMed
  75. Ross MA, Miller RG, Berchert L, Parry G, Barohn RJ, Armon C, Bryan WW, Petajan J, Stromatt S, Goodpasture J, McGuire D. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology. 1998 Mar; 50(3):768-72.
    View in: PubMed
  76. Pakiam AS, Parry GJ. Multifocal motor neuropathy without overt conduction block. Muscle Nerve. 1998 Feb; 21(2):243-5.
    View in: PubMed
  77. Campbell DA, McHale DP, Brown KA, Moynihan LM, Houseman M, Karbani G, Parry G, Janjua AH, Newton V, al-Gazali L, Markham AF, Lench NJ, Mueller RF. A new locus for non-syndromal, autosomal recessive, sensorineural hearing loss (DFNB16) maps to human chromosome 15q21-q22. J Med Genet. 1997 Dec; 34(12):1015-7.
    View in: PubMed
  78. McGuire D, Garrison L, Armon C, Barohn RJ, Bryan WW, Miller R, Parry GJ, Petajan JH, Ross MA. A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group. J Neurol Sci. 1997 Oct; 152 Suppl 1:S18-22.
    View in: PubMed
  79. Hoagland RJ, Mendoza M, Armon C, Barohn RJ, Bryan WW, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group. Muscle Nerve. 1997 Jun; 20(6):691-5.
    View in: PubMed
  80. Parry G, Roth AD. Psychotherapy research: linking efficacy to policy and practice. Epidemiol Psichiatr Soc. 1997 May-Aug; 6(2):99-106.
    View in: PubMed
  81. Miller RG, Moore D, Young LA, Armon C, Barohn RJ, Bromberg MB, Bryan WW, Gelinas DF, Mendoza MC, Neville HE, Parry GJ, Petajan JH, Ravits JM, Ringel SP, Ross MA. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group. Neurology. 1996 Dec; 47(6):1383-8.
    View in: PubMed
  82. McGuire D, Garrison L, Armon C, Barohn R, Bryan W, Miller R, Parry G, Petajan J, Ross M. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group. Neurology. 1996 May; 46(5):1442-4.
    View in: PubMed
  83. Parry GJ. AAEM case report #30: multifocal motor neuropathy. Muscle Nerve. 1996 Mar; 19(3):269-76.
    View in: PubMed
  84. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SC. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann Neurol. 1996 Feb; 39(2):256-60.
    View in: PubMed
  85. Tarnow-Mordi W, Parry G, Gould C, Fowlie P. CRIB and performance indicators for neonatal intensive care units (NICUs) Arch Dis Child Fetal Neonatal Ed. 1996 Jan; 74(1):F79-80.
    View in: PubMed
  86. Brown KA, Janjua AH, Karbani G, Parry G, Noble A, Crockford G, Bishop DT, Newton VE, Markham AF, Mueller RF. Linkage studies of non-syndromic recessive deafness (NSRD) in a family originating from the Mirpur region of Pakistan maps DFNB1 centromeric to D13S175. Hum Mol Genet. 1996 Jan; 5(1):169-73.
    View in: PubMed
  87. Bone LJ, Dahl N, Lensch MW, Chance PF, Kelly T, Le Guern E, Magi S, Parry G, Shapiro H, Wang S, et al. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology. 1995 Oct; 45(10):1863-6.
    View in: PubMed
  88. Tamura E, Parry GJ. Severe radicular pathology in rats with longstanding diabetes. J Neurol Sci. 1994 Dec 1; 127(1):29-35.
    View in: PubMed
  89. Parry GJ. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve. 1994 Jan; 17(1):97-9.
    View in: PubMed
  90. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology. 1993 Dec; 43(12):2664-7.
    View in: PubMed
  91. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology. 1993 Sep; 43(9):1806-8.
    View in: PubMed
  92. Parry GJ. Motor neuropathy with multifocal conduction block. Semin Neurol. 1993 Sep; 13(3):269-75.
    View in: PubMed
  93. Kaku DA, Malamut RI, Frey DJ, Parry GJ. Conduction block as an early sign of reversible injury in ischemic monomelic neuropathy. Neurology. 1993 Jun; 43(6):1126-30.
    View in: PubMed
  94. Kozu H, Tamura E, Parry GJ. Endoneurial blood supply to peripheral nerves is not uniform. J Neurol Sci. 1992 Sep; 111(2):204-8.
    View in: PubMed
  95. Vera-Ramirez M, Charlet M, Parry GJ. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1992 Aug; 42(8):1636-7.
    View in: PubMed
  96. Parry GJ, Ogston SA. EUROMAC. A European concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and child development at 18 months. Results--child development at age 18 months. Int J Epidemiol. 1992; 21 Suppl 1:S72-8.
    View in: PubMed
  97. Ogston SA, Parry GJ. EUROMAC. A European concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and child development at 18 months. Results--strategy of analysis and analysis of pregnancy outcome. Int J Epidemiol. 1992; 21 Suppl 1:S45-71.
    View in: PubMed
  98. Cornblath DR, Sumner AJ, Daube J, Gilliat RW, Brown WF, Parry GJ, Albers JW, Miller RG, Petajan J. Conduction block in clinical practice. Muscle Nerve. 1991 Sep; 14(9):869-71; discussion 867-8.
    View in: PubMed
  99. Parry GJ, Kozu H. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy. Neurology. 1990 Sep; 40(9):1446-9.
    View in: PubMed
  100. Shy ME, Heiman-Patterson T, Parry GJ, Tahmoush A, Evans VA, Schick PK. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy. Neurology. 1990 May; 40(5):842-4.
    View in: PubMed
  101. Day JW, Parry GJ. Normocalcemic tetany abolished by calcium infusion. Ann Neurol. 1990 Apr; 27(4):438-40.
    View in: PubMed
  102. Parry GJ, Kohzu H. Acute changes in blood glucose affect resistance to ischemic nerve conduction failure. Neurology. 1990 Jan; 40(1):107-10.
    View in: PubMed
  103. Parry GJ, Floberg J. Diabetic truncal neuropathy presenting as abdominal hernia. Neurology. 1989 Nov; 39(11):1488-90.
    View in: PubMed
  104. Parry GJ, Kohzu H. Studies of resistance to ischemic nerve conduction failure in normal and diabetic rats. J Neurol Sci. 1989 Oct; 93(1):61-7.
    View in: PubMed
  105. Miller RG, Parry GJ, Pfaeffl W, Lang W, Lippert R, Kiprov D. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve. 1988 Aug; 11(8):857-63.
    View in: PubMed
  106. Hellmann DB, Laing TJ, Petri M, Whiting-O'Keefe Q, Parry GJ. Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases. Medicine (Baltimore). 1988 May; 67(3):145-53.
    View in: PubMed
  107. Parry GJ, Linn DJ. Conduction block without demyelination following acute nerve infarction. J Neurol Sci. 1988 Apr; 84(2-3):265-73.
    View in: PubMed
  108. Aminoff MJ, Olney RK, Parry GJ, Raskin NH. Relative utility of different electrophysiologic techniques in the evaluation of brachial plexopathies. Neurology. 1988 Apr; 38(4):546-50.
    View in: PubMed
  109. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve. 1988 Feb; 11(2):103-7.
    View in: PubMed
  110. Lipkin WI, Parry G, Abrams D, Kiprov D. Polyradiculoneuropathy, polyradiculitis, and CMV in AIDS and ARC. Neurology. 1987 May; 37(5):888.
    View in: PubMed
  111. Parry GJ, Linn DJ. Remarkable resistance of the nerve to ischemia: a reply. Muscle Nerve. 1987 Feb; 10(2):183.
    View in: PubMed
  112. Parry GJ, Aminoff MJ. Somatosensory evoked potentials in chronic acquired demyelinating peripheral neuropathy. Neurology. 1987 Feb; 37(2):313-6.
    View in: PubMed
  113. Parry GJ, Linn DJ. Transient focal conduction block following experimental occlusion of the vasa nervorum. Muscle Nerve. 1986 May; 9(4):345-8.
    View in: PubMed
  114. Parry GJ, Holtz SJ, Ben-Zeev D, Drori JB. Gammopathy with proximal motor axonopathy simulating motor neuron disease. Neurology. 1986 Feb; 36(2):273-6.
    View in: PubMed
  115. Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology. 1985 Oct; 35(10):1466-8.
    View in: PubMed
  116. Lipkin WI, Parry G, Kiprov D, Abrams D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology. 1985 Oct; 35(10):1479-83.
    View in: PubMed
  117. Aminoff MJ, Goodin DS, Parry GJ, Barbaro NM, Weinstein PR, Rosenblum ML. Electrophysiologic evaluation of lumbosacral radiculopathies: electromyography, late responses, and somatosensory evoked potentials. Neurology. 1985 Oct; 35(10):1514-8.
    View in: PubMed
  118. Parry GJ. Mononeuropathy multiplex (AAEE case report #11). Muscle Nerve. 1985 Jul-Aug; 8(6):493-8.
    View in: PubMed
  119. Parry GJ, Cornblath DR, Brown MJ. Transient conduction block following acute peripheral nerve ischemia. Muscle Nerve. 1985 Jun; 8(5):409-12.
    View in: PubMed
  120. Parry GJ, Brown MJ. Arachidonate-induced experimental nerve infarction. J Neurol Sci. 1981 Apr; 50(1):123-33.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Parry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (488) concept(s)
_
Co-Authors
See all (22) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_